(Q36797217)

16 August 2017

1 reference

title

Pramipexole: in restless legs syndrome (English)

1 reference

16 August 2017

Paul L McCormack

1

1 reference

16 August 2017

M Asif A Siddiqui

series ordinal

2

1 reference

16 August 2017

publication date

1 January 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

21

1 reference

16 August 2017

issue

5

1 reference

16 August 2017

page(s)

429-37; discussion 438-40

1 reference

Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study)

16 August 2017

cites work

1 reference

12 December 2020

Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome

1 reference

12 December 2020

Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease.

1 reference

12 December 2020

Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study--the PRELUDE study

1 reference

12 December 2020

Efficacy and safety of pramipexole in restless legs syndrome

1 reference

12 December 2020

EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep

1 reference

12 December 2020

Steady-state pharmacokinetic properties of pramipexole in healthy volunteers.

1 reference

12 December 2020

Restless legs syndrome improved by pramipexole: a double-blind randomized trial

1 reference

12 December 2020

Long-term treatment with pramipexole in restless legs syndrome

1 reference

12 December 2020

Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors

1 reference

12 December 2020

Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health

1 reference

12 December 2020

Pramipexole. A review of its use in the management of early and advanced Parkinson's disease

1 reference

12 December 2020

Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome

1 reference

12 December 2020

An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder.

1 reference

12 December 2020

Controversies and challenges in defining the etiology and pathophysiology of restless legs syndrome

1 reference

12 December 2020

Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome

1 reference

12 December 2020

10.2165/00023210-200721050-00008

Identifiers

DOI

1 reference

Dimensions Publication ID

16 August 2017

1043105889

0 references

1 reference